Virtu Financial LLC I Mab Transaction History

Virtu Financial LLC

  • $1.82 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$1.18 - $3.06 $17,213 - $44,639
14,588 New
14,588 $19,000
Q3 2021

Nov 12, 2021
SELL
$57.18 - $84.43 $224,145 - $330,965
-3,920 Closed
0 $0
Q2 2021

Sep 17, 2021
BUY
$47.86 - $83.95 $187,611 - $329,084
3,920 New
3,920 $329,000

Others Institutions Holding IMAB

# of Institutions
36
Shares Held
15.5M
Call Options Held
56.4K
Put Options Held
5.8K
View Full List

About I-Mab

IMAB Quotes by TradingView
  • Ticker IMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,098,800
  • Market Cap $74.8M
  • Description
  • I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...
More about IMAB
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email